OpenLB
Open Library of Bioscience
Advanced Search
BMC neurology
Nov 21, 2017;17 (1): 201.

Cognitive rehabilitation and mindfulness in multiple sclerosis (REMIND-MS): a study protocol for a randomised controlled trial.

Ilse M Nauta, Anne E M Speckens, Roy P C Kessels, Jeroen J G Geurts, Vincent de Groot, Bernard M J Uitdehaag, Luciano Fasotti, Brigit A de Jong
Author Information
  1. Ilse M Nauta: Department of Neurology, Amsterdam Neuroscience, MS Center Amsterdam, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, the Netherlands. i.nauta1@vumc.nl.
  2. Anne E M Speckens: Department of Psychiatry, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, the Netherlands.
  3. Roy P C Kessels: Donders Institute for Brain, Cognition and Behaviour, Radboud University, PO Box 9101, 6500 HB, Nijmegen, the Netherlands.
  4. Jeroen J G Geurts: Department of Anatomy and Neurosciences, Amsterdam Neuroscience, MS Center Amsterdam, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, the Netherlands.
  5. Vincent de Groot: Department of Rehabilitation Medicine, MS Center Amsterdam, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, the Netherlands.
  6. Bernard M J Uitdehaag: Department of Neurology, Amsterdam Neuroscience, MS Center Amsterdam, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, the Netherlands.
  7. Luciano Fasotti: Donders Institute for Brain, Cognition and Behaviour, Radboud University, PO Box 9101, 6500 HB, Nijmegen, the Netherlands.
  8. Brigit A de Jong: Department of Neurology, Amsterdam Neuroscience, MS Center Amsterdam, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, the Netherlands.
PMID: 29162058 DOI: 10.1186/s12883-017-0979-y

Abstract

BACKGROUND: Cognitive problems frequently occur in patients with multiple sclerosis (MS) and profoundly affect their quality of life. So far, the best cognitive treatment options for MS patients are a matter of debate. Therefore, this study aims to investigate the effectiveness of two promising non-pharmacological treatments: cognitive rehabilitation therapy (CRT) and mindfulness-based cognitive therapy (MBCT). Furthermore, this study aims to gain additional knowledge about the aetiology of cognitive problems among MS patients, since this may help to develop and guide effective cognitive treatments.
METHODS/DESIGN: In a dual-centre, single-blind randomised controlled trial (RCT), 120 MS patients will be randomised into one of three parallel groups: CRT, MBCT or enhanced treatment as usual (ETAU). Both CRT and MBCT consist of a structured 9-week program. ETAU consists of one appointment with an MS specialist nurse. Measurements will be performed at baseline, post-intervention and 6 months after the interventions. The primary outcome measure is the level of subjective cognitive complaints. Secondary outcome measures are objective cognitive function, functional brain network measures (using magnetoencephalography), psychological symptoms, well-being, quality of life and daily life functioning.
DISCUSSION: To our knowledge, this will be the first RCT that investigates the effect of MBCT on cognitive function among MS patients. In addition, studying the effect of CRT on cognitive function may provide direction to the contradictory evidence that is currently available. This study will also provide information on changes in functional brain networks in relation to cognitive function. To conclude, this study may help to understand and treat cognitive problems among MS patients.
TRIAL REGISTRATION: This trial was prospectively registered at the Dutch Trial Registration (number NTR6459 , registered on 31 May 2017).

Keywords

Brain networks Cognition Cognitive rehabilitation therapy Mindfulness-based cognitive therapy Multiple sclerosis Randomised controlled trial

References

  1. Mult Scler. 2014 Jul;20(8):1131-4 [PMID: 24277326]
  2. Neuroimage. 2014 Mar;88:308-18 [PMID: 24161625]
  3. Clin Rehabil. 2009 Jan;23 (1):79-90 [PMID: 19114440]
  4. Clin Neurophysiol. 2012 Jun;123(6):1067-87 [PMID: 22356937]
  5. Mult Scler. 2008 Aug;14(7):972-80 [PMID: 18632779]
  6. Qual Life Res. 1995 Jun;4(3):187-206 [PMID: 7613530]
  7. Stroke. 2012 Apr;43(4):1046-51 [PMID: 22308241]
  8. Psychiatry Res. 1992 Mar;41(3):237-48 [PMID: 1594710]
  9. PLoS One. 2013 Jul 31;8(7):e69318 [PMID: 23935983]
  10. Ann Neurol. 2011 Feb;69(2):292-302 [PMID: 21387374]
  11. Brain Pathol. 2015 Jan;25(1):79-98 [PMID: 25521179]
  12. Neurosci Biobehav Rev. 2014 Jun;43:48-73 [PMID: 24705269]
  13. Disabil Rehabil. 2012;34(6):478-85 [PMID: 21978031]
  14. Nat Rev Neurosci. 2014 Oct;15(10):683-95 [PMID: 25186238]
  15. J Neurol Sci. 2012 Sep 15;320(1-2):91-6 [PMID: 22805106]
  16. Acta Psychiatr Scand. 1983 Jun;67(6):361-70 [PMID: 6880820]
  17. Clin Psychol Rev. 2011 Apr;31(3):449-64 [PMID: 21183265]
  18. Neuropsychology. 2010 Sep;24(5):573-80 [PMID: 20804245]
  19. BMC Health Serv Res. 2013 Jun 15;13:217 [PMID: 23768141]
  20. Lancet Neurol. 2008 Dec;7(12):1139-51 [PMID: 19007738]
  21. J Clin Psychol. 2011 Jan;67(1):99-110 [PMID: 20973032]
  22. Lancet Neurol. 2015 Mar;14(3):302-17 [PMID: 25662900]
  23. Curr Neurol Neurosci Rep. 2012 Oct;12(5):618-27 [PMID: 22791241]
  24. Mult Scler. 2014 Jan;20(1):99-107 [PMID: 23804555]
  25. Mult Scler. 2003 Feb;9(1):95-101 [PMID: 12617275]
  26. Community Ment Health J. 1968 Dec;4(6):443-53 [PMID: 24185570]
  27. J Neurol Sci. 2015 Jul 15;354(1-2):1-9 [PMID: 25998261]
  28. J Consult Clin Psychol. 1997 Aug;65(4):599-610 [PMID: 9256561]
  29. Neurology. 2010 Sep 28;75(13):1141-9 [PMID: 20876468]
  30. Assessment. 2011 Sep;18(3):308-20 [PMID: 21586480]
  31. Mindfulness (N Y). 2012 Mar;3(1):76-84 [PMID: 23293683]
  32. J Neurol Sci. 2013 Nov 15;334(1-2):154-60 [PMID: 24011606]
  33. Neurology. 1983 Nov;33(11):1444-52 [PMID: 6685237]
  34. Cochrane Database Syst Rev. 2014 Feb 11;(2):CD009131 [PMID: 24515630]
  35. Neuroimage. 2012 Feb 15;59(4):3909-21 [PMID: 22122866]
  36. Clin Psychol Psychother. 2011 May-Jun;18(3):250-5 [PMID: 21584907]
  37. J Int Neuropsychol Soc. 2010 Jan;16(1):118-29 [PMID: 19900348]
  38. Arch Phys Med Rehabil. 2011 Apr;92 (4):519-30 [PMID: 21440699]
  39. Mindfulness (N Y). 2017;8(5):1251-1258 [PMID: 28989549]
  40. Brain Cogn. 2014 Oct;90:32-40 [PMID: 24975229]
  41. J Int Neuropsychol Soc. 2006 Jul;12(4):549-58 [PMID: 16981607]
  42. Clin Rehabil. 2011 Jun;25(6):487-500 [PMID: 21402652]
  43. J Neuropsychol. 2011 Mar;5(Pt 1):73-113 [PMID: 21366888]
  44. Nat Rev Neurosci. 2015 Apr;16(4):213-25 [PMID: 25783612]
  45. Mult Scler. 2015 Aug;21(9):1184-94 [PMID: 25767124]

Grants

  1. 15-911/Stichting MS Research

MeSH Term

Cognition
Cognitive Behavioral Therapy
Humans
Mindfulness
Multiple Sclerosis
Quality of Life
Single-Blind Method
Time Factors
Treatment Outcome
Journal Article Randomized Controlled Trial

Word Cloud

Created with Highcharts 10.0.0cognitiveMSpatientsstudytherapyCRTMBCTtrialwillfunctionCognitiveproblemssclerosisliferehabilitationamongmayrandomisedcontrolledmultiplequalitytreatmentaimsknowledgehelpRCToneETAUoutcomemeasuresfunctionalbraineffectprovidenetworksregisteredBACKGROUND:frequentlyoccurprofoundlyaffectfarbestoptionsmatterdebateThereforeinvestigateeffectivenesstwopromisingnon-pharmacologicaltreatments:mindfulness-basedFurthermoregainadditionalaetiologysincedevelopguideeffectivetreatmentsMETHODS/DESIGN:dual-centresingle-blind120threeparallelgroups:enhancedusualconsiststructured9-weekprogramconsistsappointmentspecialistnurseMeasurementsperformedbaselinepost-intervention6 monthsinterventionsprimarymeasurelevelsubjectivecomplaintsSecondaryobjectivenetworkusingmagnetoencephalographypsychologicalsymptomswell-beingdailyfunctioningDISCUSSION:firstinvestigatesadditionstudyingdirectioncontradictoryevidencecurrentlyavailablealsoinformationchangesrelationconcludeunderstandtreatTRIALREGISTRATION:prospectivelyDutchTrialRegistrationnumberNTR645931May2017mindfulnessREMIND-MS:protocolBrainCognitionMindfulness-basedMultipleRandomised

Similar Articles

Cited By